TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A post hoc analysis of the WAHA randomized trial found that older adults assigned to eat walnuts daily had about 6% higher total IgG after two years than participants in the control group. The finding concerns an immune-system biomarker, not proof that walnuts improve immunity or prevent heart disease; the study found no significant effect on the other measured markers.
A post hoc analysis of the Walnuts and Healthy Aging (WAHA) trial found that older adults assigned to eat walnuts daily had about 6% higher total IgG after two years than those assigned to avoid walnuts. The result is a difference in an immune-system biomarker, not evidence that walnuts strengthen immunity, prevent infections or reduce cardiovascular disease; the clinical meaning remains uncertain.
The analysis, published in JACC Advances, examined blood samples from 474 participants in the larger trial: 240 in the walnut group and 234 controls. The participants were cognitively healthy adults aged 63 to 79 in the United States and Spain. The original WAHA trial focused on cognitive function and retinal integrity, while this later analysis assessed immune-related measures.
Participants assigned to the intervention ate 30 to 60 grams of walnuts daily, or about 15% of their daily energy intake, for two years. Researchers measured total immunoglobulin G (IgG) and immunoglobulin M (IgM), antibodies directed at MDA-LDL, and circulating MDA-LDL. The researchers adjusted their analyses for baseline measurements and factors including age, sex, smoking, cholesterol, body mass index, hypertension and diabetes.
The higher total IgG result appeared across both trial centers, but it was not statistically significant in the Spain-only analysis. In the US subgroup, total IgG was 11% higher in the walnut group than in controls. The researchers found no significant intervention effect on total IgM, MDA-LDL concentrations, or either class of MDA-LDL-specific antibody. Total IgG and IgM, as well as MDA-LDL-specific IgM antibodies, declined over time in both groups.
What Higher IgG Can Tell Us
IgG is a type of antibody, and its concentration in blood can reflect aspects of the body’s broader humoral immune status. A change in total IgG may be of scientific interest, but it does not by itself show that a person is better protected against infection or has a healthier immune response. The study measured a laboratory marker; it did not test whether participants experienced fewer illnesses or improved health outcomes.
The researchers examined these markers partly because immune processes are involved in atherosclerosis, the buildup of plaque in arteries. Prior research has associated some antibody measures with cardiovascular outcomes, but those associations do not establish that raising total IgG through a particular food will prevent heart disease. In this analysis, walnut consumption did not significantly change the measured MDA-LDL-specific antibodies or circulating MDA-LDL, leaving the proposed cardiovascular implications unproven.
For readers, the practical takeaway is limited: the findings add a possible immune-biomarker effect to research on walnuts and aging, but they are not a basis for treating walnuts as an immune or cardiovascular therapy. The result needs confirmation and a clearer link to outcomes that matter to patients.
Products Worth Considering
Levoit Core 400S-P Smart Air Purifier for Large Rooms
Garmin Forerunner 70 GPS Running Smartwatch, 43 mm, Black
Garmin Forerunner 55 GPS Running Smartwatch, Black
As an affiliate, we earn on qualifying purchases.
Inside the WAHA Trial
The WAHA trial randomized 708 older adults in the United States and Spain to a walnut-based or walnut-excluding diet between May 2012 and May 2014. People who already ate more than two servings of tree nuts per week were excluded, as were people regularly using certain soy lecithin, fish oil or flaxseed oil supplements. Participants had follow-up assessments every two months to monitor weight, tolerance, diet adherence and medication use.
The immune-marker report is a post hoc analysis, meaning the researchers assessed outcomes beyond the original trial’s stated focus. Blood samples from baseline and the two-year visit were available for 474 participants. Among Spanish participants, red-blood-cell alpha-linolenic acid, used as an adherence indicator, rose substantially in the walnut group and fell in controls. The investigators also reported that sensitivity analyses produced results similar to the main analysis.
Baseline immune-marker levels differed between the two countries: the report says total IgG and IgM were 25% lower among US participants than Spanish participants. That variation matters when interpreting the subgroup results, including the fact that a statistically significant difference was detected in the US but not in Spain.
“Long-term walnut consumption was associated with total serum IgG concentrations approximately 6% higher than those of controls.”
— The study authors, as reported by News-Medical
Health Effects Still Unproven
The analysis does not establish why the walnut group had higher total IgG or whether the difference affects health. It did not show fewer infections, improved immune function in daily life, or fewer cardiovascular events. Nor did it establish that the IgG change was caused by a specific nutrient in walnuts.
The result also varied by location: the US subgroup showed an 11% difference, while the Spain subgroup did not show a statistically significant intervention effect. Differences in baseline measurements and other characteristics between centers may be relevant, but the available report does not establish an explanation. The analysis included fewer participants than the full 708-person trial because immune-marker samples were available for 474.
As a post hoc analysis, the findings should be treated as exploratory rather than as definitive evidence of a health benefit. Further research would need to replicate the association and assess clinical outcomes before conclusions about immunity or heart-disease prevention could be drawn.
Evidence Needed Beyond Biomarkers
The immediate next step is independent research testing whether the IgG finding can be replicated in other populations and study settings. Studies that follow participants for clinical outcomes, rather than antibody concentrations alone, could help determine whether this biomarker difference has practical health relevance.
The source report does not identify a planned follow-up study or a specific date for further results. Until such evidence is available, the finding should be understood as an association observed in a secondary analysis of a randomized dietary trial—not as a recommendation to use walnuts to change immune function or prevent cardiovascular disease.
Key Questions
What does IgG do?
IgG is a type of antibody involved in the body’s humoral immune response. Measuring total IgG in blood gives one broad immune-related biomarker, but the level alone does not show whether someone is protected from a particular infection or has better overall health.
Did the study show that walnuts improve immunity?
No. It found higher total IgG concentrations in the walnut group after two years, but it did not test whether participants had fewer infections or better protection from illness. The authors said the clinical implications remain uncertain.
How much did participants eat?
Participants assigned to the walnut diet were asked to eat 30 to 60 grams daily for two years, representing about 15% of their daily energy intake. The study compared this group with participants assigned to a walnut-excluding diet.
Did walnuts change the other markers?
The analysis found no significant intervention effect on total IgM, circulating MDA-LDL, or MDA-LDL-specific IgM or IgG antibodies. Several markers declined over time in both groups.
Does this mean walnuts prevent heart disease?
No such conclusion can be drawn from this analysis. It examined immune and lipid-related biomarkers, not whether walnut consumption prevented cardiovascular events. The reported IgG difference has no established clinical meaning at this stage.
Source: news-medical.net
